Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × CTL019 chimeric antigen receptor × Clear all

NCT01029366 2023-06-22

CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell